Matinas BioPharma Holdings, Inc. (MTNB)
Across 12 earnings reports since Nov 08, 2021, Matinas BioPharma Holdings, Inc. (MTNB) has a clear post-earnings pattern. It moves ±9.78% on average after reporting and finishes higher 25.0% of the time. Its largest post-earnings gain was +2.2% (Mar 15, 2023) and its largest decline was -44.48% (Aug 09, 2023). The next earnings report is predicted for 2026-11-05 (estimated).
Earnings reactions
How MTNB moved on each past earnings report.
Earnings Impact
Total Earnings
12
Avg Abs. Movement
±9.78%
Positive %
25.0%
Negative %
75.0%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 14, 2024 | ☽ POST | -2.55% | open_in_new |
| May 09, 2024 | ☽ POST | -0.57% | open_in_new |
| Mar 27, 2024 | ☽ POST | -5% | open_in_new |
| Nov 08, 2023 | ☽ POST | -13.05% | open_in_new |
Earnings Count
12
Total earnings in dataset
Avg Abs. Movement
±9.78%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260904 | open_in_new SEC.gov |
| 425 | 20260825 | open_in_new SEC.gov |
| 10-Q | 20260813 | open_in_new SEC.gov |
| 4 | 20260813 | open_in_new SEC.gov |
| 4 | 20260813 | open_in_new SEC.gov |
| SCHEDULE 13D/A | 20260813 | open_in_new SEC.gov |
| 425 | 20260804 | open_in_new SEC.gov |
| 425 | 20260730 | open_in_new SEC.gov |
| 425 | 20260729 | open_in_new SEC.gov |
| 8-K | 20260724 | open_in_new SEC.gov |
Frequently asked about MTNB earnings
When does Matinas BioPharma Holdings, Inc. report earnings next? expand_more
Matinas BioPharma Holdings, Inc. (MTNB)'s next earnings date is estimated for 2026-11-05. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does MTNB stock move after earnings? expand_more
Over 12 reports, MTNB has moved an average of ±9.78% the session after earnings, closing higher 25.0% of the time.
What was MTNB's biggest post-earnings move? expand_more
MTNB's largest post-earnings gain on record was +2.2% on Mar 15, 2023, and its largest decline was -44.48% on Aug 09, 2023.
Where can I find Matinas BioPharma Holdings, Inc.'s SEC filings? expand_more
All of Matinas BioPharma Holdings, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right